E0 ConsensusPreliminaryPEM unclearSystematic-ReviewPeer-reviewedMachine draft
The Safety of Baduanjin Exercise: A Systematic Review.
Fang, Jianqi, Zhang, Liying, Wu, Fangzhen et al. · Evidence-based complementary and alternative medicine : eCAM · 2021 · DOI
Quick Summary
Baduanjin is a gentle exercise therapy from traditional Chinese medicine that is becoming more popular around the world. This review looked at 47 studies involving 3,877 people to find out what side effects people experienced when doing Baduanjin. Most studies didn't carefully track side effects, but those that did reported issues like muscle aches, heart palpitations, dizziness, knee pain, and fatigue—though it's unclear if Baduanjin actually caused these problems.
Why It Matters
Understanding the safety profile of Baduanjin is critical for ME/CFS patients considering this intervention, as post-exertional malaise and symptom exacerbation are central concerns in this population. This review identifies a significant gap in adverse event monitoring in exercise intervention trials and highlights the need for more rigorous safety reporting, which is essential for informed decision-making by ME/CFS patients.
Observed Findings
- Only 2 of 47 trials (4%) actually reported adverse events occurring during Baduanjin training despite 22 studies (47%) having protocols for monitoring.
- Reported adverse events included palpitations, giddiness, knee pain, backache, fatigue, nervousness, dizziness, shoulder pain, chest tightness, dyspnea, and myalgia.
- The vast majority of included trials (90%) did not document or report adverse event data despite the potential for harm.
- Adverse events in ME/CFS specifically mentioned included muscle ache, palpitations, giddiness, knee pain, backache, fatigue, nervousness, dizziness, shoulder pain, chest tightness, and shortness of breath.
Inferred Conclusions
- Baduanjin exercise appears to have a low reported incidence of serious adverse events based on available literature, though this may reflect underreporting rather than true safety.
- Current trial methodology is inadequate for characterizing the true safety profile of Baduanjin, as adverse event monitoring is inconsistent and poorly documented.
- Future Baduanjin trials must implement standardized adverse event monitoring protocols aligned with CONSORT guidelines to enable reliable safety assessment.
Remaining Questions
- What is the true incidence and severity of adverse events associated with Baduanjin exercise when prospectively and systematically monitored?
- Is Baduanjin safe for ME/CFS patients specifically, and does it trigger post-exertional malaise or symptom worsening?
What This Study Does Not Prove
This review does not establish that Baduanjin causes the reported adverse events—only 2 of 47 studies directly attributed adverse events to the intervention. The study cannot determine the true incidence or severity of adverse effects because most trials did not systematically monitor for them, and correlation between Baduanjin and reported symptoms cannot be inferred. No conclusions can be drawn about safety specifically in ME/CFS patients, as the review aggregated findings across diverse populations with varying conditions.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionPainFatigueSensory Sensitivity
Method Flag:Weak Case DefinitionExploratory OnlyMixed Cohort
Metadata
- DOI
- 10.1155/2021/8867098
- PMID
- 33552220
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →